Ascletis Selected Oral ASC30 and ASC48 Combination for Obesity Clinical Development

ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC50 of 1 pM in the hGIPR cAMP activation assay, exhibit...

July 17, 2026 | Friday | News
CPC Biotech Introduced RevolveSD™ Series for Faster Sterile Single-Use Bioprocess Disconnections

CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceu...

July 17, 2026 | Friday | News
Mesoblast Completes Target Enrollment in Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,  announced that it has achieved ...

July 15, 2026 | Wednesday | News
Applied StemCell and RoosterBio Partner to Advance Scalable iPSC Manufacturing

Partnership pairs Applied StemCell's induced pluripotent stem cell technology with RoosterBio's engineered media, reagents, and scalable bioprocess syste...

July 10, 2026 | Friday | News
ProBio Supports Advancement of UC Irvine and GlyTR's Next-Generation AAV CAR-T Platform Toward Clinical Development

The University of California, Irvine (UC Irvine) School of Medicine and GlyTR Therapeutics have developed a next‑generation AAV‑mediated CAR T‑cell...

July 06, 2026 | Monday | News
Nona Biosciences and Lonza Partner to Advance Next-Generation BBB-Crossing Technology for CNS Therapies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announce...

July 06, 2026 | Monday | News
Lonza Expands Strategic Biologics Partnership with Leading US Biopharma in Multi-Billion CHF Collaboration

Further expansion of the existing strategic partnership reflects continued high demand for Lonza’s high-quality global biologics outsourcing de...

July 02, 2026 | Thursday | News
Liminatus Pharma Revises Merger Agreement with InnocsAI to Accelerate Strategic Combination

Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, announced that it h...

July 02, 2026 | Thursday | News
Aptose Biosciences Completes Acquisition by Hanmi Pharmaceutical

Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company develo...

July 02, 2026 | Thursday | News
Kimball Electronics Acquires Helvoet to Expand Global Medical CDMO Platform

Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, an...

July 02, 2026 | Thursday | News
Xellar Biosystems Raises $50 Million to Advance AI-Powered 3D Bio Intelligence Platform

Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery...

July 01, 2026 | Wednesday | News
Innovent and Lilly Expand China Oncology Alliance with Verzenios Commercialization Agreement

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

July 01, 2026 | Wednesday | News
Evotec Launches J.TRAIN to Bring Continuous Biologics Manufacturing Directly to Partner Facilities

Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary continuous manufacturing pl...

July 01, 2026 | Wednesday | News
LENZ Therapeutics Partners with Arrotex to Commercialize VIZZ in Australia and New Zealand

LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Arrotex Pharmaceuticals Pty Ltd. (“Arrotex”) announced an exclusive license and commercialization ...

June 26, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close